Metastatic renal cell carcinoma to hemangioblastoma in von Hippel-Lindau disease

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 4, 2007, Pages 641-645

  Polydorides, Alexandros D ^a,b   Rosenblum, Marc K ^b   Edgar, Mark A ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD57 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; INHIBIN; INHIBIN ALPHA; NERVE CELL ADHESION MOLECULE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RECURRENCE; CASE REPORT; CENTRAL NERVOUS SYSTEM TUMOR; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; HEMANGIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LAMINECTOMY; SPINAL CORD TUMOR; VON HIPPEL LINDAU DISEASE;

CARCINOMA, RENAL CELL; CEREBELLAR NEOPLASMS; CERVICAL VERTEBRAE; FEMALE; HEMANGIOBLASTOMA; HIPPEL-LINDAU DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SPINAL CORD NEOPLASMS;

EID: 34147125874     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Postler E, Meyermann R. Brain metastasis in renal cell carcinoma: clinical data and neuropathological differential diagnoses. Anticancer Res. 1999;19:1579-1581.
2. Burger PC, Scheithauer BW, Vogel FS. Surgical Pathology of the Nervous System and Its Coverings. 4th ed. Philadelphia, Ra: Churchill Livingstone; 2002:329-335.
3. Jamjoom A, Kane N, Nicoll J. Metastasis of a renal carcinoma to a cerebellar haemangioblastoma in a case of von Hippel-Lindau disease. Neurosurg Rev. 1992;15:231-234.
4. Bret P, Streichenberger N, Guyotat J. Metastasis of renal carcinoma to a cerebellar hemangioblastoma in a patient with von Hippel Lindau disease: a case report. Br J Neurosurg. 1999;13:413-416.
5. Hamazaki S, Nakashima H, Matsumoto K, Taguchi K, Okada S. Metastasis of renal cell carcinoma to central nervous system hemangioblastoma in two patients with von Hippel-Lindau disease. Pathol Int. 2001;51:948-953.
6. Mottolese C, Stan H, Giordano F, Frappaz D, Alexei D, Streichenberger N. Metastasis of clear-cell renal carcinoma to cerebellar hemangioblastoma in von Hippel Lindau disease: rare or not investigated? Acta Neurochir. 2001;143:1059-1063.
7. Abou-Hamden A, Koszyca B, Carney PC, Sandhu N, Blumbergs PC. Metastasis of renal cell carcinoma to haemangioblastoma of the spinal cord in von Hippel-Lindau disease: case report and review of the literature. Pathology. 2003;35:224-227.
8. Altinoz MA, Santaguida C, Guiot MC, Del Maestro RF. Spinal hemangioblastoma containing metastatic renal cell carcinoma in von Hippel-Lindau disease: case report and review of the literature. J Neurosurg Spine. 2005;3:495-500.
9. Bohling T, Plate KH, Haltia MJ, Alitalo K, Neumann HPH. Von Hippel-Lindau disease and capillary hemangioblastoma. In: Kleihues P, Cavenee WK, eds. Pathology and Genetics of Tumours of the Nervous System. Lyon, France: IARC Press; 2000:223-226. World Health Organization Classification of Tumours.
10. Jung SM, Kuo TT. Immunoreactivity of CD10 and inhibin alpha in differentiating hemangioblastoma of central nervous system from metastatic clear cell renal cell carcinoma. Mod Pathol. 2005;18:788-794.
11. Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol. 2000;24:203-210.
12. McCregor DK, Khurana KK, Cao C, et al. Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody 'Renal Cell Carcinoma Marker.' Am J Surg Pathol. 2001;25:1485-1492.
13. Hoang MP, Amirkhan RH. Inhibin alpha distinguishes hemangioblastoma from clear cell renal cell carcinoma. Am J Surg Pathol. 2003;27:1152-116.
14. North PE, Mizeracki A, Mihm MC Jr, Mrak RE. GLUT1 immunoreaction patterns reliably distinguish hemangioblastoma from metastatic renal cell carcinoma. Clin Neuropathol. 2000;19:131-137.
15. Brown DF, Gazdar AF, White CL III, Yashima K, Shay JW, Rushing EJ. Human telomerase RNA expression and MIB-1 (Ki-67) proliferation index distinguish hemangioblastomas from metastatic renal cell carcinomas. J Neuropathol Exp Neurol. 1997;56:1349-1355.
16. Longatti P, Basaldella L, Orvieto E, Tos AP, Martinuzzi A. Aquaporin 1 expression in cystic hemangioblastomas. Neurosci Lett. 2006;392:178-180.
17. Crocker J, Carey MP, Allcock R. Hemangioblastoma and renal clear cell carcinoma distinguished by means of the AgNOR method. Am J Clin Pathol. 1990:93:555-557.
18. Leppert JT, Lam JS, Pantuck AJ, Figlin RA, Belldegrun AS. Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma. BJU Int. 2005;96:281-285.
19. Proescholdt MA, Mayer C, Kubitza M, et al. Expression of hypoxia-inducible carbonic anhydrases in brain tumors. Neuro-oncol. 2005;7:465-475.
20. Jensen RL, Gillespie D, House P, Layfield L, Shelton C. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression. J Neurosurg. 2004;100:488-497.
21. Neumann HPH. Basic criteria for clinical diagnosis and genetic counseling in von Hippel-Lindau syndrome. Vasa. 1987;16:220-226.
22. Decker HJ, Weidt EJ, Brieger J. The von Hippel-Lindau tumor suppressor gene: a rare and intriguing disease opening new insight into basic mechanisms of carcinogenesis. Cancer Genet Cytogenet. 1997;93:74-83.
23. Kim WY, Kaelin WC. Role of VHL gene mutation in human cancer. J Clin Oncol. 2004;22:4991-5004.
24. Ivanov SV, Kuzmin I, Wei MH, et al. Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc Natl Acad Sci USA. 1998;95:12596-12601.
25. Wykoff CC, Beasley NJ, Watson PH, et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 2000;60:7075-7083.
26. Ivanov S, Liao SY, Ivanova A, et al. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol. 2001;158:905-919.
27. Sufan RI, Jewett MA, Ohh M. The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma. Am J Physiol Renal Physiol. 2004;287:F1-F6.
28. Sella A, Ro JY. Renal cell cancer: best recipient of tumor-to-tumor metastasis. Urology. 1987;30:35-38.
29. Frank TS, Trojanowski JQ, Roberts SA, Brooks JJ. A detailed immunohistochemical analysis of cerebellar hemangioblastoma: an undifferentiated mesenchymal tumor. Mod Pathol. 1989;2:638-651.
30. Hufnagel TJ, Kim JH, True LD, Manuelidis EE. Immunohistochemistry of capillary hemangioblastoma: immunoperoxidase-labeled antibody staining resolves the differential diagnosis with metastatic renal cell carcinoma, but does not explain the histogenesis of the capillary hemangioblastoma. Am J Surg Pathol. 1989;13:207-216.
31. Clelland CA, Treip CS. Histological differentiation of metastatic renal carcinoma in the cerebellum from cerebellar haemangioblastoma in von Hippel-Lindau's disease. J Neurol Neurosurg Psychiatry. 1989;52:162-166.
32. Wizigmann-Voos S, Plate KH. Pathology, genetics and cell biology of hemangioblastomas. Histol Histopathol. 1996;11:1049-1061.
33. Bohling T, Maenpaa A, Timonen T, Vantunen L, Paetau A, Haltia M. Different expression of adhesion molecules on stromal cells and endothelial cells of capillary hemangioblastoma. Acta Neuropathol. 1996;92:461-466.
34. Roy S, Chu A, Trojanowski JQ, Zhang PJ. D2-40, a novel monoclonal antibody against the M2A antigen as a marker to distinguish hemangioblastomas from renal cell carcinomas. Acta Neuropathol. 2005;109:497-502.